Literature DB >> 21400022

Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity.

Mónica Bernal1, Angel Concha, Pablo Sáenz-López, Ana Isabel Rodríguez, Teresa Cabrera, Federico Garrido, Francisco Ruiz-Cabello.   

Abstract

PURPOSE: To analyze the correlation of genomic instability with leukocyte infiltrate in gastrointestinal carcinomas (GIACs) and with tumor immunogenicity, e.g., HLA class I cell surface expression defects and galectin-3 and PDL-1 expression. EXPERIMENTAL
DESIGN: Lymphocyte and macrophage infiltrations were immunohistochemically studied in HLA class I negative GIACs with sporadic high-level microsatellite instability (MSI-H) or microsatellite stability (MSS).
RESULTS: Tumors with MSI-H were associated with the following: dense infiltration (CD45, P < 0.001); cytotoxic CD8-positive lymphocytes (P < 0.001); and a complete absence of HLA class I cell surface expression, due to inactivating β2-microglobulin (β2-m) mutation in 50% of cases. In contrast, HLA class I negative tumors with MSS were significantly associated with fewer CD8-positive lymphocytes. There was no association between microsatellite instability and other molecular features of the tumor cells, including expression of galectin-3. Finally, macrophage infiltrate in the tumors was not correlated with microsatellite instability or HLA class I cell surface expression (CD64, P = 0.63; CD163, P = 0.51).
CONCLUSIONS: Microsatellite instability appears to be the most important factor determining the composition, density, and localization of leukocyte infiltrate, which is independent of other molecular features such expression of HLA class I cells, galectin-3, or programmed death ligand-1. Accordingly, the strong intratumoral CD8+ T infiltration of MSI-H tumors may be produced by elevated levels of specific inflammatory chemokines in the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400022     DOI: 10.1007/s00262-011-0999-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  9 in total

1.  High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.

Authors:  Jonas Janikovits; Meike Müller; Julia Krzykalla; Sandrina Körner; Fabian Echterdiek; Bernd Lahrmann; Niels Grabe; Martin Schneider; Axel Benner; Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Oncoimmunology       Date:  2017-11-06       Impact factor: 8.110

2.  TRAIL-coated leukocytes that kill cancer cells in the circulation.

Authors:  Michael J Mitchell; Elizabeth Wayne; Kuldeepsinh Rana; Chris B Schaffer; Michael R King
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

3.  Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.

Authors:  Laura S Rozek; Stephanie L Schmit; Joel K Greenson; Lynn P Tomsho; Hedy S Rennert; Gad Rennert; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2016-05-12       Impact factor: 13.506

4.  The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer.

Authors:  Jingjun Wu; Yue Lv; Nan Wang; Ying Zhao; Pengxin Zhang; Yijun Liu; Anliang Chen; Jianying Li; Xin Li; Yan Guo; Tingfan Wu; Ailian Liu
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

Review 5.  The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care.

Authors:  Marina De Rosa; Daniela Rega; Valeria Costabile; Francesca Duraturo; Antonello Niglio; Paola Izzo; Ugo Pace; Paolo Delrio
Journal:  Therap Adv Gastroenterol       Date:  2016-08-07       Impact factor: 4.409

Review 6.  Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach.

Authors:  Moisés Blanco-Calvo; Ángel Concha; Angélica Figueroa; Federico Garrido; Manuel Valladares-Ayerbes
Journal:  Int J Mol Sci       Date:  2015-06-15       Impact factor: 5.923

7.  PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence.

Authors:  Phu N Tran; Sarmen Sarkissian; Joseph Chao; Samuel J Klempner
Journal:  Gastrointest Cancer       Date:  2017-05-05

Review 8.  Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.

Authors:  Alexandre Morrot; Leonardo Marques da Fonseca; Eduardo J Salustiano; Luciana Boffoni Gentile; Luciana Conde; Alessandra Almeida Filardy; Tatiany Nunes Franklim; Kelli Monteiro da Costa; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima
Journal:  Front Oncol       Date:  2018-03-23       Impact factor: 6.244

9.  Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.

Authors:  Hernani Gil-Julio; Francisco Perea; Antonio Rodriguez-Nicolas; Jose Manuel Cozar; Amanda Rocío González-Ramirez; Angel Concha; Federico Garrido; Natalia Aptsiauri; Francisco Ruiz-Cabello
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.